Biolegend, 338804, FITC anti-human CD44 Antibody, 100tests

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from a low or mid level of intensity to high expression levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.
100tests
Verified Reactivity: Human
Reported Reactivity: African Green, Baboon, Cynomolgus, Rhesus
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: Normal human PBL
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography and conjugated with FITC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Blue Laser (488 nm)
Application References(PubMed link indicates BioLegend citation): Kishimoto T, et al. eds. 1997 Leucocyte Typing VI:White Cell Differentiation Antigen. Garland Publishing Inc.
Product Citations: Yusa K, et al. 2016. Sci Rep. 6:29462. PubMed Kim E, et al. 2020. Cancer Cell Int. 1.072916667. PubMed Xin Y, et al. 2021. Stem Cell Res Ther. 49:12. PubMed Knapp D,et al. 2017. Cell Rep.. 10.1016/j.celrep.2017.09.096. PubMed Zhao Q, et al. 2018. Cancer Res. 78:2370. PubMed Thirant C, et al. 2023. Nat Commun. 14:2575. PubMed Ishiuchi N, et al. 2023. Stem Cell Res Ther. 14:121. PubMed Ferreira-Baptista C, et al. 2022. Bioengineering (Basel). 9: . PubMed Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed Wang G, et al. 2021. J Cell Mol Med. 25:6584. PubMed Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed Zhang Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.06.037. PubMed Guney-Esken G, et al. 2021. Stem Cell Res Ther. 12:287. PubMed Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed Vaziri N, et al. 2021. Life (Basel). 11:. PubMed Tian X, et al. 2018. IUBMB Life. 70:224. PubMed Liu Z, et al. 2021. Molecules. 26:. PubMed Brisard D, et al. 2018. Oncotarget. 9:37305. PubMed Gao X, et al. 2022. Front Cell Dev Biol. 9:788331. PubMed Byun JS, et al. 2020. J Biol Chem. 295:13677. PubMed Widowati W, et al. 2018. Acta Inform Med. 26:240. PubMed Ruan S, et al. 2020. Front Pharmacol. 11:150. PubMed Liu T, et al. 2019. Oncol Lett. 18:2262. PubMed Xu H, et al. 2022. Cell Death Dis. 13:478. PubMed Wang X, et al. 2021. Front Endocrinol (Lausanne). 12:666195. PubMed Hofmann M, et al. 2012. PLoS One. 7:e39520. PubMed Qing P, et al. 2020. Exp Physiol. 1708:105. PubMed Yang C et al. 2019. Int J Mol Med. 43(3):1395-1405 . PubMed Ayhan S, et al. 2021. Journal of Cell Science. 134(6):. PubMed Saga R, et al. 2019. J Radiat Res. 60:298. PubMed Zhang Y, et al. 2018. Stem Cells Int. 2018:7159465. PubMed Keshtkar S, et al. 2021. Stem Cells Int. 8857457:2020. PubMed Guney-Esken G, et al. 2021. Methods Mol Biol. 2549:23. PubMed Meng Z, et al. 2022. Stem Cell Res Ther. 13:466. PubMed He Z, et al. 2020. J Exp Clin Cancer Res. 39:140. PubMed Khera L, et al. 2021. Life Sci Alliance. 4: . PubMed Wang X, et al. 2021. Inflammation. 44:1815. PubMed Liu XZ, et al. 2022. Nat Commun. 13:69. PubMed
RRID: AB_1501204 (BioLegend Cat. No. 338803) AB_1501197 (BioLegend Cat. No. 338804)
Structure: Variable splicing of CD44 gene generates many CD44 isoforms, 85 kD
Distribution: All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells
Function: Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor: Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type: Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area: Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family: Adhesion Molecules, CD Molecules
Antigen References: 1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Haynes BF, et al. 1991. Cancer Cells 3:347. 3. Goldstein LA, et al. 1989. Cell 56:1063. 4. Mikecz K, et al. 1995. Nat. Med. 1:558.
Gene ID: 960
UniProt: View information about CD44 on UniProt.org
Clone: BJ18
Regulatory Status: RUO
Workshop: VI A034
Other Names: Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype: Mouse IgG1, κ